FEDI, SANDRA
FEDI, SANDRA
Medicina Sperimentale e Clinica
A hypercoagulable and hypofibrinolytic state is detectable by global methods in patients with retinal vein occlusion.
2012 Cellai AP;Lami D;Fedi S;Marcucci R;Mannini L;Cenci C;Rogolino A;Sodi A;Menchini U;Abbate R;Prisco D
A meta-analysis of potential risks of of low levels of protein Z for diseases related to vascular thrombosis
2010 F.Sofi; F.Cesari; R.Abbate; G.F.Gensini; GJ. Broze; S.Fedi
A mixture of bupivacaine and fentanyl in epidural block in orthopedic surgery: effects on blood coagulation and fibrinolysys
1987 FS.Rucci; R.Fiaschi; S.Fedi; A.Fontanelli; E.Rosi; V.Boddi
A proinflammatory state is associated with hyperhomocysteinemia in the elderly
2005 AM. GORI; AM. CORSI; S. FEDI; A. GAZZINI; F. SOFI; B. BARTALI; B. BANDINELLI; GF. GENSINI; R. ABBATE; L. FERRUCCI
Accuracy of a Point-of-Care system for PT/INR test performed in the hospital anticoagulation clinic
2012 R. Paniccia; R. Marcucci; L. Mannini; D. Poli; S. Fedi; A. Alessandrello Liotta; M. Pagliuca; G. Cappelli; S. Sequi; R. Abbate.
ACE DD genotype: an independent predisposition factor to venous thromboembolism.
2003 FATINI C; GENSINI F; STICCHI E; BATTAGLINI B; PRISCO D; FEDI S; BRUNELLI T; MARCUCCI R; A. CONTI; GENSINI GF; ABBATE R
Acquired activated protein C resistance in postmenopausal women is dependent on factor VIII:c levels.
1999 Marcucci R; Abbate R; Fedi S; Gori AM; Brunelli T; Bruni V; Bucciantini S; Micheli S; Pepe G; Prisco D; Gensini GF.
Activation of the coagulation system during electrophysiologic invasive study with and without ablation
1997 A. Michelucci; L. Padeletti; E. Antonucci; A. A. Conti; A. A. Liotta; S. Fedi; D. Prisco; R. Abbate; G. F. Gensini
Activation of the immune system and coronary artery disease: the role of anti-endothelial cell antibodies.
2001 A. FARSI; T. BRUNELLI; A. GORI; S. FEDI; GF. GENSINI; D. PRISCO; A. PASSALEVA; R. ABBATE; M. DOMENEGHETTI; C. GIGLIOLI; P. MERONI; N. DEL PAPA
Acute pyhase proteins in alcoholics with or without liver injury
1992 G.Lippi; S.Fedi; M.Grassi; E.Rosi. AA.Liotta; A.Fontanelli; AP.Cellai; R.Mazzanti
Alterations of haemorheological parameters in patients with Peripheral Arterial Disease
2013 I. Ricci; F. Sofi; A. Alessandrello Liotta; S. Fedi; C. Macchi; G. Pratesi; R. Pulli; C. Pratesi; R. Abbate; L. Mannini
Angiotensi-converting enzyme DD genotype, angiotensin type 1 receptor CC genotype, and hyperhomocysteinmeia increase first-trimester fetal-loss susceptibility
2000 C. Fatini; F. Gensini; B. Battaglini; D. Prisco; A.P. Cellai; S. Fedi; R. Marcucci; T. Brunelli; G. Mello; E. Parretti; G. Pepe; R. Abbate
Angiotensin converting enzyme DD genotype affects the changes of plasma plasminogen activator inhibitor-1 activity after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction patients
2000 D.Prisco; C.Fatini; B.Battaglini; F.Gensini; S.Fedi; M.Falai; M.Chioccioli; AM.Gori; M.Margheri; GF.Gensini
Anticoagulant effect of dabigatran, rivaroxaban or apixaban treatment on different laboratory hemostasis tests in patients with atrial fibrillation
2014 Paniccia, Rita; Priora, Raffaella; Alessandrello Liotta, Agatina; Proietti Petretti, Alessia; Tafuro, Eleonora; Puri, Riccardo; Fedi, Sandra; Pazzi, Maddalena; Poli, Daniela; Marcucci, Rossella; Abbate, Rosanna
Antiphospholipid antibodies (aPL) increase the potential monocyte procoagulant activity in patients with systemic lupus erythematosus
1996 F.Martini; A.Farsi; AM.Gori; M.Boddi; S.Fedi; MP.Domeneghetti; A.Passaleva; D.Prisco; R.Abbate
Antiphospholipid antibodies : a new risk factor for restenosis after percutaneous transluminal coronary angioplasty?
1998 L. Chiarugi; D.Prisco; M.Capanni; M. Capanni; E. Antoniucci; S. Fedi; A.Alessandrello Liotta; M.Margheri; C.Giglioli; P.R. Dabizzi; I.Simonetti; R.Abbate; G.F. Gensini.
Antiphospholipid antibodies and pregnancy disorders in women with insulin dependent diabetes
1996 M.Boddi; D.Prisco; S.Fedi; AP.Cellai; AA.Liotta; E.Parretti; F.Mecacci; G.Mello; R.Abbate
Atherosclerotic and thrombophilic risk factors in patients with ischemic central retinal vein occlusion
2011 A.Sodi; B.Giambene; R.Marcucci; F.Sofi; S.Fedi; R.Abbate; G.F.Gensini; U.Menchini
Blood clotting activation during normal pregnancy
1996 P.Comeglio; S.Fedi; AA.Liotta; AP.Cellai; E.Chiarantini; D.Prisco; F.Mecacci; E.Parretti; G.Mello; R.Abbate
Changes in fibrinolysis after primary PTCA
1999 E.Antonucci; S.Fedi; M.Falai; A.Lombardi; M.Chioggioli; A.Rogolino; I.Simonetti; C.Giglioli; M.Capanni; L.Chiarugi; GF.Gensini
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A hypercoagulable and hypofibrinolytic state is detectable by global methods in patients with retinal vein occlusion. | 2012 | Cellai AP;Lami D;Fedi S;Marcucci R;Mannini L;Cenci C;Rogolino A;Sodi A;Menchini U;Abbate R;Prisco D | |
| A meta-analysis of potential risks of of low levels of protein Z for diseases related to vascular thrombosis | 2010 | F.Sofi; F.Cesari; R.Abbate; G.F.Gensini; GJ. Broze; S.Fedi | |
| A mixture of bupivacaine and fentanyl in epidural block in orthopedic surgery: effects on blood coagulation and fibrinolysys | 1987 | FS.Rucci; R.Fiaschi; S.Fedi; A.Fontanelli; E.Rosi; V.Boddi | |
| A proinflammatory state is associated with hyperhomocysteinemia in the elderly | 2005 | AM. GORI; AM. CORSI; S. FEDI; A. GAZZINI; F. SOFI; B. BARTALI; B. BANDINELLI; GF. GENSINI; R. ABBATE; L. FERRUCCI | |
| Accuracy of a Point-of-Care system for PT/INR test performed in the hospital anticoagulation clinic | 2012 | R. Paniccia; R. Marcucci; L. Mannini; D. Poli; S. Fedi; A. Alessandrello Liotta; M. Pagliuca; G. Cappelli; S. Sequi; R. Abbate. | |
| ACE DD genotype: an independent predisposition factor to venous thromboembolism. | 2003 | FATINI C; GENSINI F; STICCHI E; BATTAGLINI B; PRISCO D; FEDI S; BRUNELLI T; MARCUCCI R; A. CONTI; GENSINI GF; ABBATE R | |
| Acquired activated protein C resistance in postmenopausal women is dependent on factor VIII:c levels. | 1999 | Marcucci R; Abbate R; Fedi S; Gori AM; Brunelli T; Bruni V; Bucciantini S; Micheli S; Pepe G; Prisco D; Gensini GF. | |
| Activation of the coagulation system during electrophysiologic invasive study with and without ablation | 1997 | A. Michelucci; L. Padeletti; E. Antonucci; A. A. Conti; A. A. Liotta; S. Fedi; D. Prisco; R. Abbate; G. F. Gensini | |
| Activation of the immune system and coronary artery disease: the role of anti-endothelial cell antibodies. | 2001 | A. FARSI; T. BRUNELLI; A. GORI; S. FEDI; GF. GENSINI; D. PRISCO; A. PASSALEVA; R. ABBATE; M. DOMENEGHETTI; C. GIGLIOLI; P. MERONI; N. DEL PAPA | |
| Acute pyhase proteins in alcoholics with or without liver injury | 1992 | G.Lippi; S.Fedi; M.Grassi; E.Rosi. AA.Liotta; A.Fontanelli; AP.Cellai; R.Mazzanti | |
| Alterations of haemorheological parameters in patients with Peripheral Arterial Disease | 2013 | I. Ricci; F. Sofi; A. Alessandrello Liotta; S. Fedi; C. Macchi; G. Pratesi; R. Pulli; C. Pratesi; R. Abbate; L. Mannini | |
| Angiotensi-converting enzyme DD genotype, angiotensin type 1 receptor CC genotype, and hyperhomocysteinmeia increase first-trimester fetal-loss susceptibility | 2000 | C. Fatini; F. Gensini; B. Battaglini; D. Prisco; A.P. Cellai; S. Fedi; R. Marcucci; T. Brunelli; G. Mello; E. Parretti; G. Pepe; R. Abbate | |
| Angiotensin converting enzyme DD genotype affects the changes of plasma plasminogen activator inhibitor-1 activity after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction patients | 2000 | D.Prisco; C.Fatini; B.Battaglini; F.Gensini; S.Fedi; M.Falai; M.Chioccioli; AM.Gori; M.Margheri; GF.Gensini | |
| Anticoagulant effect of dabigatran, rivaroxaban or apixaban treatment on different laboratory hemostasis tests in patients with atrial fibrillation | 2014 | Paniccia, Rita; Priora, Raffaella; Alessandrello Liotta, Agatina; Proietti Petretti, Alessia; Tafuro, Eleonora; Puri, Riccardo; Fedi, Sandra; Pazzi, Maddalena; Poli, Daniela; Marcucci, Rossella; Abbate, Rosanna | |
| Antiphospholipid antibodies (aPL) increase the potential monocyte procoagulant activity in patients with systemic lupus erythematosus | 1996 | F.Martini; A.Farsi; AM.Gori; M.Boddi; S.Fedi; MP.Domeneghetti; A.Passaleva; D.Prisco; R.Abbate | |
| Antiphospholipid antibodies : a new risk factor for restenosis after percutaneous transluminal coronary angioplasty? | 1998 | L. Chiarugi; D.Prisco; M.Capanni; M. Capanni; E. Antoniucci; S. Fedi; A.Alessandrello Liotta; M.Margheri; C.Giglioli; P.R. Dabizzi; I.Simonetti; R.Abbate; G.F. Gensini. | |
| Antiphospholipid antibodies and pregnancy disorders in women with insulin dependent diabetes | 1996 | M.Boddi; D.Prisco; S.Fedi; AP.Cellai; AA.Liotta; E.Parretti; F.Mecacci; G.Mello; R.Abbate | |
| Atherosclerotic and thrombophilic risk factors in patients with ischemic central retinal vein occlusion | 2011 | A.Sodi; B.Giambene; R.Marcucci; F.Sofi; S.Fedi; R.Abbate; G.F.Gensini; U.Menchini | |
| Blood clotting activation during normal pregnancy | 1996 | P.Comeglio; S.Fedi; AA.Liotta; AP.Cellai; E.Chiarantini; D.Prisco; F.Mecacci; E.Parretti; G.Mello; R.Abbate | |
| Changes in fibrinolysis after primary PTCA | 1999 | E.Antonucci; S.Fedi; M.Falai; A.Lombardi; M.Chioggioli; A.Rogolino; I.Simonetti; C.Giglioli; M.Capanni; L.Chiarugi; GF.Gensini |